Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Viatris
VTRS
$19B
| $3.42M | ﹤0.01% |
252,774
-5,270
| -2% | -$74.8K |
|
|
VMW
427
DELISTED
VMware, Inc
VMW
| $3.39M | ﹤0.01% |
22,796
-50
| -0.2% | -$7.58K |
|
428
Ingersoll Rand
IR
$34.2B
| $3.35M | ﹤0.01% |
66,440
+46,522
| +234% | +$2.37M |
|
429
State Street Energy Select Sector SPDR ETF
XLE
$38.1B
| $3.26M | ﹤0.01% |
125,112
-11,242
| -8% | -$279K |
|
430
Rexford Industrial Realty
REXR
$8.14B
| $3.25M | ﹤0.01% |
57,214
+8,008
| +16% | +$483K |
|
431
Check Point Software Technologies
CHKP
$12.8B
| $3.24M | ﹤0.01% |
28,655
-53
| -0.2% | -$6.46K |
|
|
TMHC
432
DELISTED
Taylor Morrison
TMHC
| $3.17M | ﹤0.01% |
122,829
-2,749
| -2% | -$72.8K |
|
433
Skyworks Solutions
SWKS
$10.1B
| $3.1M | ﹤0.01% |
+18,834
| New | +$3.44M |
|
434
First Merchants
FRME
$2.69B
| $3.09M | ﹤0.01% |
73,901
+6,982
| +10% | +$284K |
|
435
Regeneron Pharmaceuticals
REGN
$79.5B
| $3.07M | ﹤0.01% |
5,074
-85
| -2% | -$52.8K |
|
436
Installed Building Products
IBP
$6.52B
| $3.04M | ﹤0.01% |
28,346
+6,428
| +29% | +$766K |
|
437
Tesla
TSLA
$1.26T
| $3M | ﹤0.01% |
11,619
-2,373
| -17% | -$559K |
|
438
Sarepta Therapeutics
SRPT
$1.77B
| $2.91M | ﹤0.01% |
31,442
+3,474
| +12% | +$268K |
|
439
IQVIA
IQV
$38.3B
| $2.9M | ﹤0.01% |
12,085
+750
| +7% | +$189K |
|
440
Texas Pacific Land
TPL
$24.5B
| $2.89M | ﹤0.01% |
21,501
+13,500
| +169% | +$2.1M |
|
441
Verizon
VZ
$195B
| $2.75M | ﹤0.01% |
50,945
+4,137
| +9% | +$229K |
|
442
iShares Global Consumer Staples ETF
KXI
$1.07B
| $2.72M | ﹤0.01% |
45,378
-1,403
| -3% | -$86.6K |
|
443
Alkermes
ALKS
$8.11B
| $2.72M | ﹤0.01% |
88,208
-595
| -0.7% | -$16.8K |
|
|
CDMO
444
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $2.71M | ﹤0.01% |
125,845
+11,222
| +10% | +$271K |
|
445
Incyte
INCY
$24B
| $2.67M | ﹤0.01% |
38,862
+3,476
| +10% | +$264K |
|
446
First Solar
FSLR
$26.2B
| $2.66M | ﹤0.01% |
27,892
+3,844
| +16% | +$357K |
|
447
M/I Homes
MHO
$3.71B
| $2.66M | ﹤0.01% |
45,951
+9,158
| +25% | +$561K |
|
|
CCMP
448
DELISTED
CMC Materials, Inc. Common Stock
CCMP
| $2.57M | ﹤0.01% |
20,870
+4,099
| +24% | +$546K |
|
449
T. Rowe Price
TROW
$24.2B
| $2.55M | ﹤0.01% |
12,948
+402
| +3% | +$84.7K |
|
|
JOBS
450
DELISTED
51job Inc
JOBS
| $2.53M | ﹤0.01% |
36,334
-23,884
| -40% | -$1.76M |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.